Legal & General Group
IPSC icon

Legal & General Group’s Century Therapeutics IPSC Stock Holding History

Legal & General Group’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,976
Closed -$1.89K – 3474
2025
Q1 		$1.89K Hold
3,976
– – ﹤0.01% 3357
2024
Q4 		$4.02K Hold
3,976
– – ﹤0.01% 3356
2024
Q3 		$6.78K Hold
3,976
– – ﹤0.01% 3342
2024
Q2 		$10.1K Buy
3,976
+1,863
+88% +$5.89K ﹤0.01% 3294
2024
Q1 		$8.83K Hold
2,113
– – ﹤0.01% 3226
2023
Q4 		$7K Hold
2,113
– – ﹤0.01% 3283
2023
Q3 		$4.23K Hold
2,113
– – ﹤0.01% 3372
2023
Q2 		$6.68K Hold
2,113
– – ﹤0.01% 3360
2023
Q1 		$7.33K Hold
2,113
– – ﹤0.01% 3253
2022
Q4 		$10.8K Buy
2,113
+414
+24% +$3.91K ﹤0.01% 3254
2022
Q3 		$17K Sell
1,699
-291
-15% -$3.06K ﹤0.01% 3245
2022
Q2 		$17K Buy
1,990
+330
+20% +$3.24K ﹤0.01% 3292
2022
Q1 		$21K Buy
1,660
+555
+50% +$7.35K ﹤0.01% 3232
2021
Q4 		$17K Hold
1,105
– – ﹤0.01% 3325
2021
Q3 		$28K Buy
1,105
+105
+11% +$2.84K ﹤0.01% 3151
2021
Q2 		$29K Buy
+1,000
New +$25.4K ﹤0.01% 3146

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legal & General Group's IPSC Position: Q2 2025 in Review

Legal & General Group sold out of Century Therapeutics (IPSC) in Q2 2025, closing a stake of 3,976 shares — an estimated $1.89K sold.

Legal & General Group first reported a position in IPSC in Q2 2021 and held it in 16 quarters. The position peaked at $29K in Q2 2021. 65 funds tracked by Wall St. Rank hold IPSC as of Q2 2025.

  • Legal & General Group reported no remaining Century Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 3,976 Century Therapeutics shares in Q2 2025, an estimated $1.89K.
  • Legal & General Group first reported a position in Century Therapeutics in Q2 2021 and held it in 16 quarters.
  • Legal & General Group's Century Therapeutics position peaked at $29K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.